2023 ESC Guidelines for the management of cardiomyopathiesElena Arbelo, Ulf Landmesser, Giuseppe Limongelli et al.|European Heart Journal|2023Cited by 2.3k
Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial DiseasesPablo García‐Pavía, Aleš Linhart, Claudio Rapezzi et al.|European Heart Journal|2021Cited by 1.1k
Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and treatment of autoimmune and inflammatory diseasesGiulio Cavalli, Charles A. Dinarello, Serena Colafrancesco et al.|Autoimmunity Reviews|2021Cited by 330
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology <scp>W</scp> orking <scp>G</scp> roup on <scp>M</scp> yocardial and <scp>P</scp> ericardial <scp>D</scp> iseasesPablo García‐Pavía, Aleš Linhart, Claudio Rapezzi et al.|European Journal of Heart Failure|2021Cited by 330
Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial DiseaseAlida L.P. Caforio, Aleš Linhart, Yehuda Adler et al.|European Heart Journal|2017Cited by 263